Atrium Therapeutics, Inc. (RNA)
12.36
+0.19
(+1.56%)
USD |
NASDAQ |
Jun 04, 16:00
12.36
0.00 (0.00%)
After-Hours: 18:09
Atrium Therapeutics Total Liabilities (Quarterly) : 58.26M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | 8.486M |
| Exicure, Inc. | 10.66M |
| Century Therapeutics, Inc. | 61.81M |
| Absci Corp. | 23.62M |
| Celularity, Inc. | 340.96M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 292.36M |
| Shareholders Equity (Quarterly) | 234.10M |
| Debt to Equity Ratio | 0.0114 |
| Current Ratio | 13.04 |
| Net Debt Paydown Yield | 0.09% |